IRIS
GALETTI, Maricla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.545
NA - Nord America 2.227
AS - Asia 835
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.609
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.207
CN - Cina 667
IT - Italia 661
FI - Finlandia 500
IE - Irlanda 488
SE - Svezia 419
DE - Germania 165
UA - Ucraina 128
TR - Turchia 75
IN - India 48
FR - Francia 38
AT - Austria 37
GB - Regno Unito 34
BE - Belgio 32
SG - Singapore 17
CA - Canada 16
NL - Olanda 14
VN - Vietnam 10
HK - Hong Kong 8
ES - Italia 6
IR - Iran 6
CH - Svizzera 4
CZ - Repubblica Ceca 4
MX - Messico 4
RU - Federazione Russa 4
PL - Polonia 3
RO - Romania 3
HU - Ungheria 2
EU - Europa 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.609
Salva come PNG Salva come JPEG
Città #
Dublin 488
Chandler 474
Ann Arbor 273
Parma 271
Jacksonville 158
Dearborn 153
Beijing 150
Ashburn 127
Nanjing 97
Princeton 74
Izmir 72
Shanghai 70
New York 63
Bremen 57
San Mateo 51
Wilmington 47
Boardman 39
Shenyang 39
Vienna 37
Nanchang 35
Kunming 30
Des Moines 28
Hefei 27
Jinan 26
Modena 23
Helsinki 22
Los Angeles 22
Rome 22
Hebei 21
Seattle 21
Tianjin 21
Milan 16
Bologna 15
Brussels 15
Redmond 15
Jiaxing 14
Changsha 13
Norwalk 13
Pune 13
Toronto 13
Houston 12
Leawood 12
Wayne 12
Woodbridge 12
Dong Ket 10
Guangzhou 10
Reggio Emilia 10
Zhengzhou 10
Amsterdam 9
Augusta 8
Fremont 8
Hong Kong 8
Ningbo 8
Binche 7
Düsseldorf 7
Haikou 7
Neviano degli Arduini 7
Redwood City 7
Falls Church 6
Fuzhou 6
Hangzhou 6
Leuven 6
Monmouth Junction 6
Montecchio Emilia 6
Piacenza 6
Taiyuan 6
Castello Molina di Fiemme 5
Chengdu 5
Grafing 5
Ardabil 4
Chongqing 4
Garza García 4
Lanzhou 4
Mestre 4
Mirandola 4
Mons 4
Munich 4
Reggio Nell'emilia 4
Torino 4
Turin 4
Xian 4
Albano Laziale 3
Albignasego 3
Borgonovo Val Tidone 3
Borås 3
Cuneo 3
Desio 3
Fairfield 3
Gainesville 3
Genoa 3
Kocaeli 3
Kraków 3
London 3
Paris 3
Prata Di Pordenone 3
Rubiera 3
Sassuolo 3
Savignano sul Rubicone 3
Shaoxing 3
Singapore 3
Totale 3.497
Salva come PNG Salva come JPEG
Nome #
Highly-defined bioprinting of long-term vascularized scaffolds with Bio-Trap: Complex geometry functionalization and process parameters with computer aided tissue engineering 145
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats 134
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 120
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib 115
Nanoparticles exposure: In-vitro and in-vivo investigation to evaluate cardiovascu1ar risk factors in normal and failing cardiac tissue [Esposizione a nanoparticelle: Studi in-vitro ed in-vivo per valutare i fattori di rischio cardiovascolari in cuori normali e patologici] 103
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 99
Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer 99
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. 97
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 94
Titanium dioxide aggregating nanoparticles induce autophagy and under-expression of microRNA 21 and 30a in A549 cell line: A comparative study with cobalt(II, III) oxide nanoparticles 93
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 92
Targeting PI3K somatic mutations reduces invasion and EMT in squamous cell carcinoma of the lung 91
New MDR1 inhibitors for overcoming multidrug resistance 89
Synthesis of Fe3O4 superparamagnetic nanoparticles and anchoring via ‘click’ chemistry to SiC/SiO2 nanowires for radiofrequency magnetic field hyperthermia 88
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 88
Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells 87
Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion 85
Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line 84
Autophagy and apoptosis: studies on the effects of bisthiosemicarbazone copper(II) complexes on p53 and p53-null tumour cell lines 84
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 84
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification 83
Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines 82
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 81
SiC/SiO2/M-NP core/shell nanowires functionalized with fluorinated porphyrins 81
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines 80
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 80
Cytocompatibility and Cellular Internalization Mechanisms of SiC/SiO2 Nanowires 79
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 78
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 78
A three-fold novel nanosystem made by SiC/SiO2 core/shell nanowires functionalized with magnetic nanoparticles and substituted porphyrin for nanomedicine applications 77
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer 76
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial 76
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines 76
Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line 75
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. (Cavazzoni and Bonelli co-first authors) 75
Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations 72
Gefitinib metabolism by CYP1A1 affects biological responses in NSCLC cell lines. 69
Synergistic activity of letrozole and sorafenib on MCF7/AROM-1 breast cancer cells 69
Anti-proliferative and pro-apoptotic effects of Sorafenib in breast cancer cells in vitro. 69
Coordinated inducible expression of p53 and FHIT has a strong anti proliferative effect in Calu-1 lung cancer cell line. 68
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines 68
5-benzylidene-hydantoin UPR 1024 acts as EGFR inhibitor and induces DNA damage in A549 NSCLC cell line 68
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells 67
New strategies to overcome resistance to EGFR tyrosine kinase inhibitors in non small cell lung cancer 66
CDK4/6 inhibitors overcome resistance to osimertinib in NSCLC cell lines independently from resistance mechanisms 64
SiO2/SiC core-shell nanowires for nanomedicine applications 64
Cytocompatible 3C-SiC/SiO2 core shell nanowires for bimodal cancer therapy 62
Modulazione della riespressione del gene FHIT in cellule di carcinoma polmonare 61
Role of cell gefitinib metabolism in the response of NSCLC cell lines to gefitinib. 61
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 61
Study and characterization of a new magnetic nanocomposite system for nanomedicine 60
Association of serum C3 concentration and histologic signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated renal vasculitis 60
Three-Dimensional Bioprinting of Organoid-Based Scaffolds (OBST) for Long-Term Nanoparticle Toxicology Investigation 59
Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer 59
Effect of constitutive or inducible expression of the FHIT gene in a lung cancer cell line 59
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 58
SiO2/SiC core-shell nanowires for nanomedicine applications 57
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones 57
The inducible coexpression of p53 and FHIT has a synergistic anti-proliferative effect in calu-1 lung cancer cell line 56
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion 56
Effects of FGFR1 inhibition on survival, proliferation, and energy metabolism in Non Small Cell Lung Cancer (NSCLC) cell lines 55
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 53
Anti-proliferative effect of induced Fhit expression in non small cell lung cancer cell line (Calu-1) 53
Cardiac kinematic parameters computed from video of in situ beating heart 53
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells 52
Optimizing EGFR inhibitor treatment in non small cell lung cancer 52
Synergistic activity of letrozole and sorafenib on breast cancer cells 50
The maintenance of gefitinib inhibits migration and epithelial-mesenchimal transition of Non-small cell lung cancer cell lines that have become resistant after prolonged gefitinib treatment 49
CDK4/6 INHIBITORS AS A NEW THERAPEUTIC APPROACH IN MESOTHELIOMA MODELS 48
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling 48
Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines 48
Espressione Inducibile del gene FHIT in cellule di carcinoma polmonare 47
Studio dell’espressione del gene FHIT in cellule di carcinoma polmonare 46
Effect of inducile FHIT and p53 expression in Calu-1 lung cancer cell line. 46
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 45
New irreversible inhibitors of EGFR tyrosine kinase activity to circumvent iressa resistance 44
T-DM1: a new therapeutic approach in HER-2 overexpressing NSCLC cell lines 44
Espressione inducibile di Fhit e p53 in cellule di carcinoma polmonare non a piccole cellule 36
In vitro characterization of efflux and metabolism of gefitinib 36
null 31
Interaction between occupational radon exposure and tobacco smoke: a systematic review 28
Chapter 9 - Innovation in nanomedicine and engineered nanomaterials for therapeutic purposes 26
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC) 23
Interaction between Occupational and Non-Occupational Arsenic Exposure and Tobacco Smoke on Lung Cancerogenesis: A Systematic Review 22
A Photoactive Supramolecular Complex Targeting PD-L1 Reveals a Weak Correlation between Photoactivation Efficiency and Receptor Expression Levels in Non-Small-Cell Lung Cancer Tumor Models 15
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines 8
Effect of inducible Fhit and p53 expression in Calu-1 lung cancer cell line 5
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators 5
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models 2
Totale 5.788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.821
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019105 0 0 0 0 0 0 0 0 0 0 92 13
2019/20201.085 160 191 42 10 66 125 145 47 117 90 40 52
2020/2021569 9 48 37 34 54 26 46 44 106 23 101 41
2021/2022427 30 19 22 29 15 9 56 36 23 24 24 140
2022/20231.873 151 225 122 118 172 208 18 138 599 17 78 27
2023/2024718 44 77 49 37 68 175 78 91 39 59 1 0
Totale 5.788